SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

10 Nov 2022 Evaluate
With no major difference for the quarter endedSeptember 2022 , the total revenue stood at Rs. 3833.42  millions.Net Profit of the company move down -52.00% to Rs. 165.24  millions from Rs. 344.28 millions  in the same quarter last year.Operating Profit reported a sharp decline to 279.58 millions from 488.03 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 3833.42 3693.88 3.78 6577.39 7346.19 -10.47 14492.67 11124.23 30.28
Other Income 8.74 119.74 -92.70 15.83 135.57 -88.32 102.35 117.74 -13.07
PBIDT 279.58 488.03 -42.71 422.76 930.29 -54.56 1393.72 1241.47 12.26
Interest 4.74 0.00 0.00 8.69 2.11 311.85 -73.66 17.88 -511.97
PBDT 274.84 488.03 -43.68 414.07 928.18 -55.39 1467.38 1223.59 19.92
Depreciation 44.64 57.01 -21.70 88.35 110.97 -20.38 211.95 281.10 -24.60
PBT 230.20 431.02 -46.59 325.72 817.21 -60.14 1255.43 942.49 33.20
TAX 64.96 86.74 -25.11 91.73 164.46 -44.22 244.81 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 24.83 0.00 0.00
PAT 165.24 344.28 -52.00 233.99 652.75 -64.15 1010.62 942.49 7.23
Equity 1022.27 899.59 13.64 1022.27 899.59 13.64 955.59 899.59 6.23
PBIDTM(%) 7.29 13.21 -44.80 6.43 12.66 -49.24 9.62 11.16 -13.83

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×